Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Desethylchloroquine-d4 is intended for use as an internal standard for the quantification of desethylchloroquine (Item No. 30113) by GC- or LC-MS. Desethylchloroquine is an active metabolite of chloroquine (Item Nos. 14194 | 30708) and hydroxychloroquine (Item Nos. 17911 | 30709).1,2 It is formed from chloroquine and hydroxychloroquine by the cytochrome P450 (CYP) isoforms CYP2C8, CYP3A4, and CYP2D6. Desethylchloroquine (20 µM) inhibits Zika virus-induced plaque formation in Vero cells when used during viral entry or post-entry.3 It protects against the cytopathic effect (CPE) of Zika virus strains PLCal_ZV, MR 766, and PRVABC59 in Vero cells (EC50s = 7.01, 10.15, and 10.72 µM, respectively). Desethylchloroquine also inhibits the growth of the chloroquine-sensitive P. falciparum strain LA 136 with a reduction in activity against the multidrug-resistant P. falciparum Smith strain in vitro (IC50s = 7.8 and 210 ng/ml, respectively).4
WARNING This product is not for human or veterinary use.
1. In vitro metabolism of chloroquine: Identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-
2. Hydroxychloroquine is metabolized by cytochrome P450 2D6, 3A4, and 2C8, and inhibits cytochrome P450 2D6, while its metabolites also inhibit cytochrome P450 3A in vitro. Drug Metab. Dispos. 51(3), 293-305 (2023).
3. Antimalarial drugs and their metabolites are potent Zika virus inhibitors. J. Med. Virol. 91(7), 1182-1190 (2019).
4. In vitro assessment of the antimalarial activity of chloroquine and its major metabolites. Ann. Trop. Med. Parasitol. 78(6), 581-585 (1984).